Gilteritinib

About

Therapy type: Targeted therapy

Therapy strategy: FLT3 inhibition

Mappings

NCI Thesaurus: Gilteritinib (coding:ncit:C116722)

RxNorm: gilteritinib (coding:rxcui:2105806, coding:omop:1355513)

SNOMED: Gilteritinib (coding:sctid:782974005, coding:omop:37204341)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
FDA (1) HC (1) FLT3-ITD Acute Myeloid Leukemia Gilteritinib
FDA (1) HC (1) FLT3 p.D835Y Acute Myeloid Leukemia Gilteritinib
FDA (1) HC (1) FLT3 p.D835A Acute Myeloid Leukemia Gilteritinib
FDA (1) HC (1) FLT3 p.D835E Acute Myeloid Leukemia Gilteritinib
FDA (1) HC (1) FLT3 p.D835H Acute Myeloid Leukemia Gilteritinib
FDA (1) HC (1) FLT3 p.D835N Acute Myeloid Leukemia Gilteritinib
FDA (1) HC (1) FLT3 p.D835S Acute Myeloid Leukemia Gilteritinib
FDA (1) HC (1) FLT3 p.D835V Acute Myeloid Leukemia Gilteritinib